DK310779A - Fremgangsmaade til fremstilling af pyrimidinonderivater - Google Patents

Fremgangsmaade til fremstilling af pyrimidinonderivater

Info

Publication number
DK310779A
DK310779A DK310779A DK310779A DK310779A DK 310779 A DK310779 A DK 310779A DK 310779 A DK310779 A DK 310779A DK 310779 A DK310779 A DK 310779A DK 310779 A DK310779 A DK 310779A
Authority
DK
Denmark
Prior art keywords
pyrimidino
derivatives
procedure
preparation
pyrimidino derivatives
Prior art date
Application number
DK310779A
Other languages
Danish (da)
English (en)
Inventor
B J Price
J W Clitherow
J Bradshaw
M Martin-Smith
D B Judd
R Hayes
Original Assignee
Glazo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glazo Group Ltd filed Critical Glazo Group Ltd
Publication of DK310779A publication Critical patent/DK310779A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK310779A 1978-07-26 1979-07-23 Fremgangsmaade til fremstilling af pyrimidinonderivater DK310779A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7831153 1978-07-26

Publications (1)

Publication Number Publication Date
DK310779A true DK310779A (da) 1980-02-29

Family

ID=10498669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK310779A DK310779A (da) 1978-07-26 1979-07-23 Fremgangsmaade til fremstilling af pyrimidinonderivater

Country Status (14)

Country Link
US (1) US4524071A (fr)
JP (1) JPS5540670A (fr)
AU (1) AU534744B2 (fr)
BE (1) BE877889A (fr)
CH (1) CH642952A5 (fr)
DE (1) DE2928842A1 (fr)
DK (1) DK310779A (fr)
ES (1) ES482869A1 (fr)
FR (1) FR2433527A1 (fr)
GB (1) GB2030979B (fr)
IT (1) IT1117778B (fr)
NL (1) NL7905775A (fr)
SE (1) SE7906372L (fr)
ZA (1) ZA793443B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
CA1155842A (fr) * 1980-03-29 1983-10-25 Thomas H. Brown Composes
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4607107A (en) * 1980-10-01 1986-08-19 Smith Kline & French Laboratories Ltd. (4-aminoalkyl-2-pyridyl alkyl)guanidines
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPS58110681A (ja) * 1981-12-23 1983-07-01 Showa Denko Kk 純鉄の錆取り方法
IT1153066B (it) * 1982-11-18 1987-01-14 Mentedison S P A Derivati del pirimidin-4-one ad attivita' erbicida
PT77623B (en) * 1982-11-25 1986-03-19 Smith Kline French Lab Process for the preparation of a small class of histamine h2-antagonists
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JO1410B1 (en) * 1984-11-03 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Vehicles
JPS61155373A (ja) * 1984-12-28 1986-07-15 Yamanouchi Pharmaceut Co Ltd 新規な2−置換アミノ−4(1h)−ピリミドン誘導体及びその製造法
JPH02101170A (ja) * 1988-10-07 1990-04-12 Mitsubishi Electric Corp アルミニウム合金表面の前処理方法
JPH04323392A (ja) * 1991-04-19 1992-11-12 Nkk Corp チタン材の酸洗処理方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (fr) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab

Also Published As

Publication number Publication date
FR2433527B1 (fr) 1982-10-15
AU4924979A (en) 1980-01-31
DE2928842A1 (de) 1980-02-14
AU534744B2 (en) 1984-02-16
IT1117778B (it) 1986-02-24
ES482869A1 (es) 1980-09-01
SE7906372L (sv) 1980-01-28
GB2030979A (en) 1980-04-16
NL7905775A (nl) 1980-01-29
IT7949849A0 (it) 1979-07-24
FR2433527A1 (fr) 1980-03-14
BE877889A (fr) 1979-11-16
ZA793443B (en) 1980-12-31
CH642952A5 (de) 1984-05-15
GB2030979B (en) 1983-03-02
JPS5540670A (en) 1980-03-22
US4524071A (en) 1985-06-18

Similar Documents

Publication Publication Date Title
DK46079A (da) Fremgangsmaade til fremstilling af alkylendiaminderivater
DK158225C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK546080A (da) Fremgangsmaade til fremstilling af galactosaccharosederivater
DK266479A (da) Fremgangsmaade til fremstilling af 3-aminopropoxyarylderivater
DK197279A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK365280A (da) Fremgangsmaade til fremstilling af ftaliminderivater
DK310779A (da) Fremgangsmaade til fremstilling af pyrimidinonderivater
DK303079A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK394080A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK552180A (da) Fremgangsmaade til fremstilling af tetrapeptidsemikarbazidderivater
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK533979A (da) Fremgangsmaade til fremstilling af thiazolylderivater
DK187980A (da) Fremgangsmaade til fremstilling af benzimidazolderivater
DK415379A (da) Fremgangsmaade til fremstilling af chromanolderivater
DK304080A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK222880A (da) Fremgangsmaade til fremstilling af anthracyclinonderivater
DK522180A (da) Fremgangsmaade til fremstilling af indolderivater
DK186279A (da) Fremgangsmaade til fremstilling af alkylcarbapenemderivater
DK350079A (da) Fremgangsmaade til fremstilling af indolinderivater
DK293779A (da) Fremgangsmaade til fremstilling af 1-fenyl-1-propanol-derivater
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK348179A (da) Fremgangsmaade til fremstilling af carbazolyderivater
DK428079A (da) Fremgangsmaade til fremstilling af cyclohexadienderivater
DK157017C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK546180A (da) Fremgangsmaade til fremstilling af triazepinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment